secwatch.observer — SEC 8-K summary
======================================

Issuer:     Profound Medical Corp. (PROF)
CIK:        0001628808
Form:       8-K
Filed at:   2025-11-12T23:59:59+00:00
Accession:  0001171843-25-007221
Event type: other_material
Sentiment:  positive
Materiality: 0.50
Item codes: 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Profound Medical signs exclusive Saudi distribution deal for TULSA-PRO and Sonalleve with Al Faisaliah Medical Systems
--------------------------------------------------------------------------------

- Exclusive distribution and supply agreement for TULSA-PRO and Sonalleve in Saudi Arabia with Al Faisaliah Medical Systems Co.
- All regulatory approvals to import and sell the technologies in Saudi Arabia are already in place.
- Saudi Arabia is the largest healthcare market in the Middle East; deal expands Profound's presence.
- CEO Arun Menawat says FMS has a proven track record in introducing advanced medical technologies in the Kingdom.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1628808/000117184325007221/0001171843-25-007221-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1628808/000117184325007221/f8k_111125.htm
  HTML page:      https://secwatch.observer/filing/0001171843-25-007221

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer